Global Pharmacogenomics Technology (Theranostics & CDx) Supply, Demand and Key Producers, 2026-2032

The global Pharmacogenomics Technology (Theranostics & CDx) market size is expected to reach $ 37150 million by 2032, rising at a market growth of 14.4% CAGR during the forecast period (2026-2032).

Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.

This report studies the global Pharmacogenomics Technology (Theranostics & CDx) demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmacogenomics Technology (Theranostics & CDx), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmacogenomics Technology (Theranostics & CDx) that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Pharmacogenomics Technology (Theranostics & CDx) total market, 2021-2032, (USD Million)

Global Pharmacogenomics Technology (Theranostics & CDx) total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Pharmacogenomics Technology (Theranostics & CDx) total market, key domestic companies, and share, (USD Million)

Global Pharmacogenomics Technology (Theranostics & CDx) revenue by player, revenue and market share 2021-2026, (USD Million)

Global Pharmacogenomics Technology (Theranostics & CDx) total market by Type, CAGR, 2021-2032, (USD Million)

Global Pharmacogenomics Technology (Theranostics & CDx) total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Pharmacogenomics Technology (Theranostics & CDx) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Agilent, Abbott, Thermofisher, Qiagen, Guardant Health, MGI Tech Co., Ltd., Amoydx Biology, Genomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pharmacogenomics Technology (Theranostics & CDx) market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Pharmacogenomics Technology (Theranostics & CDx) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmentation by Type:
Instrument
Reagents and Consumables
Others

Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmentation by Application:
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others

Companies Profiled:
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics

Key Questions Answered

1. How big is the global Pharmacogenomics Technology (Theranostics & CDx) market?

2. What is the demand of the global Pharmacogenomics Technology (Theranostics & CDx) market?

3. What is the year over year growth of the global Pharmacogenomics Technology (Theranostics & CDx) market?

4. What is the total value of the global Pharmacogenomics Technology (Theranostics & CDx) market?

5. Who are the Major Players in the global Pharmacogenomics Technology (Theranostics & CDx) market?

6. What are the growth factors driving the market demand? Show more